Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival
Michael Dietachmayr1,2, Abirami Rathakrishnan1,2, Oleksandra Karpiuk1,2
1Department of Medicine III, Klinikum rechts der Isar, Technical University of Munich, 81675, Munich, Germany.
Abstract:
Regulation of mitosis secures cellular integrity and its failure critically contributes to the development, maintenance, and treatment resistance of cancer. In yeast, the dual phosphatase Cdc14 controls mitotic progression by antagonizing Cdk1-mediated protein phosphorylation. By contrast, specific mitotic functions of the mammalian Cdc14 orthologue CDC14B have remained largely elusive. Here, we find that CDC14B antagonizes CDK1-mediated activating mitotic phosphorylation of the deubiquitinase USP9X at serine residue 2563, which we show to be essential for USP9X to mediate mitotic survival. Starting from an unbiased proteome-wide screening approach, we specify Wilms' tumor protein 1 (WT1) as the relevant substrate that becomes deubiquitylated and stabilized by serine 2563-phosphorylated USP9X in mitosis. We further demonstrate that WT1 functions as a mitotic transcription factor and specify CXCL8/IL-8 as a target gene of WT1 that conveys mitotic survival. Together, we describe a ubiquitin-dependent signaling pathway that directs a mitosis-specific transcription program to regulate mitotic survival.
Insights
The CDC14B phosphatase regulates mitotic survival by deubiquitylating USP9X, a key enzyme. This process stabilizes Wilms' tumor protein 1 (WT1), a mitotic transcription factor essential for cell survival during mitosis.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Mitotic regulation is crucial for cellular integrity, and its disruption is linked to cancer development and treatment resistance.
- The Cdc14 phosphatase family plays a role in controlling mitosis, but the specific functions of its mammalian orthologue, CDC14B, are not well understood.
Purpose of the Study:
- To elucidate the specific mitotic functions of the mammalian CDC14B orthologue.
- To identify substrates and pathways regulated by CDC14B during mitosis.
Main Methods:
- Proteome-wide screening to identify CDC14B-interacting proteins and substrates.
- Phosphorylation site analysis (serine 2563) on USP9X.
- Ubiquitination and stabilization assays for WT1.
- Analysis of WT1's role as a mitotic transcription factor and its target genes.
Main Results:
- CDC14B antagonizes CDK1-mediated phosphorylation of USP9X at serine 2563, which is essential for mitotic survival.
- Phosphorylated USP9X deubiquitylates and stabilizes Wilms' tumor protein 1 (WT1).
- WT1 acts as a mitotic transcription factor, regulating the expression of CXCL8/IL-8 to promote mitotic survival.
Conclusions:
- A novel ubiquitin-dependent signaling pathway regulates mitotic survival.
- This pathway involves CDC14B, USP9X, and WT1, directing a mitosis-specific transcription program.
- Understanding this pathway offers potential insights into cancer biology and therapeutic strategies.
Related Concept Videos
Inhibition of Cdk Activity
Anaphase Promoting Complex
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Abnormal Proliferation


